Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake

Cancer Research

Volumn 67, Issue 1, 2007, Pages 417-424

  Huffman, Derek M ^a   Johnson, Maria S ^a   Watts, Amanda ^a   Elgavish, Ada ^b   Eltoum, Isam A ^c   Nagy, Tim R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; TESTOSTERONE;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC RESTRICTION; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; ENERGY BALANCE; FEEDING; FEMALE; FOOD INTAKE; LEAN BODY WEIGHT; MALE; METASTASIS; MOUSE; NONHUMAN; OVERNUTRITION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN BLOOD LEVEL; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; TRANSGENIC MOUSE;

ADENOCARCINOMA; ADIPONECTIN; ANIMALS; BODY COMPOSITION; CALORIC RESTRICTION; DISEASE PROGRESSION; EATING; ENERGY METABOLISM; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; PROSTATIC NEOPLASMS; TESTIS; TESTOSTERONE;

EID: 33846422735     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1244     Document Type: Article

References (50)

1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
3. Berrigan D, Lavigne JA, Perkins SN, et al. Phenotypic effects of calorie restriction and insulin-like growth factor-1 treatment on body composition and bone mineral density of C57BL/6 mice: implications for cancer prevention. In Vivo 2005;19:667-74.
4. Mukherjee P, Abate LE, Seyfried TN. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 2004;10:5622-9.
5. Dirx MJ, Zeegers MP, Dagnelie PC, van den Bogaard T, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer 2003;106:766-70.
6. Bertrand HA, Lynd FT, Masoro EJ, Yu BP. Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet. J Gerontol 1980;35:827-35.
7. Harrison DE, Archer JR, Astle CM. Effects of food restriction on aging: separation of food intake and adiposity. Proc Natl Acad Sci U S A 1984;81:1835-8.
8. Kealy RD, Lawler DF, Ballam JM, et al. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 2002;220:1315-20.
9. Stuchlikova E, Juricova-Horakova M, Deyl Z. New aspects of the dietary effect of life prolongation in rodents. What is the role of obesity in aging? Exp Gerontol 1975;10:141-4.
10. Barzilai N, Gupta G. Revisiting the role of fat mass in the life extension induced by caloric restriction. J Gerontol A Biol Sci Med Sci 1999;54:B89-96; discussion B7-8.
11. Gower BA, Weinsier RL, Jordan JM, Hunter GR, Desmond R. Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women. Am J Clin Nutr 2002;76:923-7.
12. Monzillo LU, Hamdy O, Horton ES, et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003;11:1048-54.
13. Kopp HP, Krzyzanowska K, Mohlig M, et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes Relat Metab Disord 2005;29:766-71.
14. Mohn A, Catino M, Capanna R, et al. Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. J Clin Endocrinol Metab 2005;90:2653-8.
15. Iyengar P, Combs TP, Shah SJ, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilisation. Oncogene 2003;22:6408-23.
16. Schoen RE, Weissfeld JL, Kuller LH, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005;129:464-75.
17. Schiff R, Reddy P, Ahotupa M, et al. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Natl Cancer Inst 2000;92:1926-34.
18. Larsson SC, Permert J, Hakansson N, et al. Overall obesity, abdominal adiposity, diabetes, and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005;93:1310-5.
19. Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria Br J Cancer 2005;93:1062-7.
20. Hu X Juneja SC, Maihle NJ, Cleary MP. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 2002;94:1704-11.
21. Frankenberry KA, Somasundar P, McFadden DW, Vona-Davis LC. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg 2004;188:560-5.
22. 2-terminal kinase. J Biol Chem 2003;278:42660-7.
23. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004;84:277-359.
24. Greenberg NM, DeMayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995;92:3439-43.
25. Nagy TR, Clair AL. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 2000;8:392-8.
26. Powell CS, Blaylock ML, Wang R, et al. Effects of energy expenditure and Ucp1 on photoperiod-induced weight gain in collard lemmings. Obes Res 2002;10:541-50.
27. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1-9.
28. Folkvord JM, Viders D, Coleman-Smith A, Clark HA. Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem 1989;37:105-13.
29. Wechter WJ, Leipold DD, Murray ED, Jr., et al. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 2000;60:2203-8.
30. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001;61:6777-82.
31. Bursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-52.
32. Masoro EJ. Commentary on "Revisiting the role of fat mass in the life extension induced by caloric restriction." J Gerontol A Biol Sci Med Sci 1999;54A:B97.
33. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-4.
34. Zhang Y, Proenca R. Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
35. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005;184:285-93.
36. van Dijk G. The role of leptin in the regulation of energy balance and adiposity. J Neuroendocrinol 2001;13:913-21.
37. Kutlu S, Canpolat S, Aydin M, et al. Exogenous leptin increases lipid peroxidation in the mouse brain. Tohoku J Exp Med 2005;206:233-6.
38. Catalano S, Marsico S, Giordano C, et al. Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J Biol Chem 2003;278:28668-76.
39. Minocci A, Savia G, Lucantoni R, et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 2000;24:1139-44.
40. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
41. Asayama K, Hayashibe H, Dobashi K, et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003;11:1072-9.
42. Bub JD, Miyazaki T, Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 2006;340:1158-66.
43. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-8.
44. Hursting SD, Switzer BR, French JE, Kari FW. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res 1993;53:2750-7.
45. Mantzoros C, Petridou F, Dessypris N, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004;89:1102-7.
46. Goktas S, Yilmaz MI, Caglar K, et al. Prostate cancer and adiponectin. Urology 2005;65:1168-72.
47. Petridou E, Mantzoros C, Dessypris N, et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 2003;88:993-7.
48. Gingrich JR, Barrios RJ, Kattan MW, et al. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 1997;57:4687-91.
49. Chen H, Luo L, Liu J, Brown T, Zirkin BR. Aging and caloric restriction: effects on Leydig cell steroidogenesis. Exp Gerontol 2005;40:498-505.
50. Colbert LH, Mai V, Tooze JA, et al. Negative energy balance induced by voluntary wheel running inhibits polyp development in APCMin mice. Carcinogenesis 2006;37:2103-7.